SILVER SPRING, Md. (MedPage Today) -- A new injectable diabetes drug is associated with low rates of cardiovascular events, but may be linked to a small increase in thyroid cancer, an FDA analysis showed.
Tags: Endocrinology by MedPage Today Endocrinology
Comments Off